Browsing by Author Armstrong, Paul W.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2003International variation in the use of evidence-based medicines for acute coronary syndromesSimes, Robert John; Armstrong, Paul W.; Califf, Robert M.; Chang, Wei-Ching; Granger, Christopher B.; Kramer, Judith M.; Lee, Kyu-Haeng; Newby, Laura Kristin; Piegas, Leopoldo S.; Topol, Eric J.; Van de Werf, Frans J.; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreInternational variation in the use of evidence-based medicines for acute coronary syndromes, European Heart Journal, vol.24,(23),2003,pp 2133-2141
2005Letter regarding article by Armstrong et al, "Lessons learned from a clinical trial" - ResponseSimes, Robert John; Armstrong, Paul W.; Califf, Robert; Granger, Christopher B.; Lee, Kerry L; Newby, L Kristin; Van de Werf, Frans; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreLetter regarding article by Armstrong et al, "Lessons learned from a clinical trial" - Response, Circulation (Baltimore), vol.111, 23,pp e393-e393
2010Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.Marschner, Ian; O'Connell, Rachel; Simes, Robert John; Armstrong, Paul W.; Aylward, Philip E G; Califf, Robert M.; Diaz, Raphael; French, John K; Granger, Christopher B.; Van de Werf, Frans; Varshavsky, Sergei; White, Harvey D.; Wilcox, Robert G; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreUnexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial., American Heart Journal, vol.159, 6,pp 988-997